Circulating osteogenic endothelial progenitor cell counts: new biomarker for the severity of coronary artery disease

International Journal of Cardiology

Volumn 227, Issue , 2017, Pages 833-839

  Yang, Shi Wei ^a,b,c,d   Hennessy, Rebecca R ^a   Khosla, Sundeep ^a   Lennon, Ryan ^a   Loeffler, Darrell ^a   Sun, Tao ^a   Liu, Zhi ^a   Park, Kyoung Ha ^a   Wang, Fei Long ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c BEIJING INSTITUTE OF HEART   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

All cause mortality; Circulating endothelial progenitor cells; Coronary artery disease severity; Osteocalcin

Indexed keywords

BIOLOGICAL MARKER; CD133 ANTIGEN; CD34 ANTIGEN; CREATININE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BONE METABOLISM; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CELL COUNT; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; AGED; BLOOD; BONE DEVELOPMENT; DIAGNOSTIC IMAGING; METABOLISM; MIDDLE AGED; MORTALITY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CORONARY ARTERY DISEASE; ENDOTHELIAL PROGENITOR CELLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OSTEOGENESIS; SEVERITY OF ILLNESS INDEX;

EID: 85006003449     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.10.036     Document Type: Article

References (39)

1. [1] Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., et al. Heart Disease and Stroke Statistics-2016 Update: a report from the American Heart Association. Circulation 133:4 (2016), e38–360.
2. [2] Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 385, 2015, 117–171.
3. [3] Schmidt-Lucke, C., Rössig, L., Fichtlscherer, S., Vasa, M., Britten, M., Kämper, U., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005), 2981–2987.
4. [4] Urbich, C., Dimmeler, S., Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95 (2004), 343–353.
5. [5] Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353 (2005), 999–1007.
6. [6] Hill, J.M., Zalos, G., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348 (2003), 593–600.
7. [7] Friedrich, E.B., Walenta, K., Scharlau, J., Nickenig, G., Werner, N., CD34 −/CD133 +/VEGFR-2 + endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ. Res. 98 (2006), e20–e25.
8. [8] Tanko, L.B., Christiansen, C., Cox, D.A., Geiger, M.J., McNabb, M.A., Cummings, S.R., Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J. Bone Miner. Res. 20 (2005), 1912–1920.
9. [9] Cejka, D., Weber, M., Diarra, D., Reiter, T., Kainberger, F., Haas, M., Inverse association between bone microarchitecture assessed by HR-pQCT and coronary artery calcification in patients with end-stage renal disease. Bone 64 (2014), 33–38.
10. [10] Freedman, B.I., Register, T.C., Effect of race and genetics on vitamin D metabolism, bone and vascular health. Nat. Rev. Nephrol. 8 (2012), 459–466.
11. [11] Persy, V., D'Haese, P., Vascular calcification and bone disease: the calcification paradox. Trends Mol. Med. 15 (2009), 405–416.
12. [12] Polonsky, T.S., Blumenthal, R.S., Greenland, P., Coronary artery calcium score. JAMA 312 (2014), 837–838.
13. [13] Chertow, G.M., Block, G.A., Correa-Rotter, R., Drüeke, T.B., Floege, J., Goodman, W.G., et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N. Engl. J. Med. 367 (2012), 2482–2494.
14. [14] Gossl, M., Modder, U.I., Atkinson, E.J., Lerman, A., Khosla, S., Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J. Am. Coll. Cardiol. 52 (2008), 1314–1325.
15. [15] Gossl, M., Modder, U.I., Gulati, R., Rihal, C.S., Prasad, A., Loeffler, D., et al. Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. Eur. Heart J. 31 (2010), 2909–2914.
16. [16] Flammer, A.J., Gossl, M., Widmer, R.J., Reriani, M., Lennon, R., Loeffler, D., et al. Osteocalcin positive CD133 +/CD34 −/KDR + progenitor cells as an independent marker for unstable atherosclerosis. Eur. Heart J. 33 (2012), 2963–2969.
17. [17] Zoch, M.L., Clemens, T.L., Riddle, R.C., New insights into the biology of osteocalcin. Bone 82 (2016), 42–49.
18. [18] Shaw, L.J., Hausleiter, J., Achenbach, S., Al-Mallah, M., Berman, D.S., Budoff, M.J., et al. Coronary computed tomographic angiography as a gatekeeper to invasive diagnostic and surgical procedures: results from the multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: an International Multicenter) registry. J. Am. Coll. Cardiol. 60 (2012), 2103–2114.
19. [19] Ross, R., The pathogenesis of atherosclerosis—an update. N. Engl. J. Med. 314 (1986), 488–500.
20. [20] Dzau, V.J., Braun-Dullaeus, R.C., Sedding, D.G., Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8 (2002), 1249–1256.
21. [21] Carmeliet, P., Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6 (2000), 389–395.
22. [22] Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997), 964–967.
23. [23] Kong, D., Melo, L.G., Mangi, A.A., Zhang, L., Lopez-Ilasaca, M., Perrella, M.A., et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109 (2004), 1769–1775.
24. [24] Werner, N., Priller, J., Laufs, U., Endres, M., Bohm, M., Dirnagl, U., et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler. Thromb. Vasc. Biol. 22 (2002), 1567–1572.
25. [25] Vasa, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A.M., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001), 2885–2890.
26. [26] Yamamoto, K., Kondo, T., Suzuki, S., Izawa, H., Kobayashi, M., Emi, N., et al. Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler. Thromb. Vasc. Biol. 24 (2004), e192–e196.
27. [27] Fadini, G.P., Miorin, M., Facco, M., Bonamico, S., Baesso, I., Grego, F., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. 45 (2005), 1449–1457.
28. [28] Matsumoto, Y., Adams, V., Walther, C., Kleinecke, C., Brugger, P., Linke, A., et al. Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair. Eur. Heart J. 30 (2009), 346–355.
29. [29] Cheng, S., Cohen, K.S., Shaw, S.Y., Larson, M.G., Hwang, S.J., McCabe, E.L., et al. Association of colony-forming units with coronary artery and abdominal aortic calcification. Circulation 122 (2010), 1176–1182.
30. [30] George, J., Goldstein, E., Abashidze, S., Deutsch, V., Shmilovich, H., Finkelstein, A., et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur. Heart J. 25 (2004), 1003–1008.
31. [31] Guven, H., Shepherd, R.M., Bach, R.G., Capoccia, B.J., Link, D.C., The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J. Am. Coll. Cardiol. 48 (2006), 1579–1587.
32. [32] Hristov, M., Erl, W., Weber, P.C., Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol. 23 (2003), 1185–1189.
33. [33] Sambrook, P.N., Chen, C.J., March, L., Cameron, I.D., Cumming, R.G., Lord, S.R., et al. High bone turnover is an independent predictor of mortality in the frail elderly. J. Bone Miner. Res. 21 (2006), 549–555.
34. [34] Tondreau, T., Meuleman, N., Delforge, A., Dejeneffe, M., Leroy, R., Massy, M., et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23 (2005), 1105–1112.
35. [35] Wexler, L., Brundage, B., Crouse, J., Detrano, R., Fuster, V., Maddahi, J., et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing group. Circulation 94 (1996), 1175–1192.
36. [36] Virmani, R., Burke, A.P., Farb, A., Kolodgie, F.D., Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 47 (2006), C13–C18.
37. [37] Collin, J., Gössl, M., Matsuo, Y., Cilluffo, R.R., Flammer, A.J., Loeffler, D., et al. Osteogenic monocytes within the coronary circulation and their association with plaque vulnerability in patients with early atherosclerosis. Int. J. Cardiol. 181 (2015), 57–64.
38. [38] Burke, A.P., Weber, D.K., Kolodgie, F.D., Farb, A., Taylor, A.J., Virmani, R., Pathophysiology of calcium deposition in coronary arteries. Herz 26 (2001), 239–244.
39. [39] Kragel, A.H., Gertz, S.D., Roberts, W.C., Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction. J. Am. Coll. Cardiol. 18 (1991), 801–808.